Drug Discovery News recently reported a proposed change to the National Institute of Health’s (NIH) policy on financial conflict of interest (FCOI) disclosure. Under the proposed regulation, academic institutions will assume responsibility for reporting to the NIH any FCOI above $5,000. Currently, individual scientists, (as opposed to institutions), are responsible for reporting FCOIs in excess of $10,000.
It is hoped that moving the disclosure obligation from the individual scientist to the institution will be accompanied by the implementation of a systematic review process and technological infrastructure only available at the institutional level.
Although the proposed changes will make the system more robust and transparent, it will also make it more difficult for multi-disciplinary teams comprised of both academic and industrial scientists to secure NIH Phase I funding. This may slow down the pace of “translational” research since most “bench-to-bedside” studies are comprised of teams from both academia and industry.
Over the last number of years we have seen a significant push towards funding “translational” academic research which may be more palpable to the general public than pure academic science. Government funding of granting agencies is partially based on the electorate’s perception of what’s important in the current environment. Since it is easier to convince Joe Public of the importance of translational research projects which hold the promise of directly and “immediately” impacting on their medical well-being, translational research grants have become more in vogue than pure academic research. However, translation research is expensive and requires contributions from both academia and industry.
What do you consider more important?
A) Implementing a more transparent and robust FCOI disclosure policy which may slow down the progress of translational research.
B) Maintaining a more relaxed policy that can keep up with the current growth rate in biomedical research but runs the risk allowing research projects to be influenced by industrial strategic interests.